Scinai leadership to showcase company's cgmp biologics cdmo and innovative i&i pipeline during bio-europe 2024

Jerusalem , oct. 31, 2024 /prnewswire/ -- scinai immunotherapeutics ltd. (nasdaq: scni), a biopharmaceutical company specializing in inflammation and immunology (i&i) biological products and providing cdmo services through its scinai bioservices unit, today announced that it will be showcasing its innovative i&i product pipeline in partnership meetings and exhibiting its cdmo services at the bio-europe 2024 conference, taking place november 4-6 in stockholm, sweden.
CDMO Ratings Summary
CDMO Quant Ranking